In a model of T1D, empagliflozin, a SGLT2 inhibitor, preserved mitochondrial quality control in renal tubular cells cultured in diabetic conditions [264], suggesting that the renoprotective effect of SGLT2 may be mediated by maintaining mitochondrial integrity. The gene discussed is SLC5A2; the disease is type 1 diabetes mellitus.